What’s the point?
In an ideal world, tissue would be restored perfectly back to its inherent function and structure. This notion of optimized healing is the foundation for StimLabs' conception. StimLabs believes in optimizing the healing cascade by advancing research and development within regenerative medicine.
Regenerative medicine is a broad research and translational field that includes tissue engineering but also incorporates research on self-healing, whereby the body uses its own system, sometimes with the assistance from external biological materials to recreate cells and rebuild tissues.1 As this field continues to evolve we have directed the short and long term strategic goals for StimLabs around this basic principle of influencing the healing cascade which aligns with the core fundamentals of regenerative medicine. Current technologies in medical devices, pharmaceuticals, and tissue banking provide useful products contributing to these fundamentals. StimLabs believes the key to optimized healing is at the intersection of these three industries.
Built with our vision in mind, StimLabs was not created to be just a tissue company. We are assembled as a regenerative medicine company. All past decisions were based solely off this idea. Our staff, our quality system, and our physical work space were all selected meticulously with the future in mind. We are not here just to turn a profit; we are here to make a long-term impact on regenerative medicine.
During this journey, StimLabs vows to always adhere to these three notions:
StimLabs is focused on creating an impact. In order to do so, it’s important our products are applicable and available to the large-majority of patients. Our products will always be developed with the intention of broad application.
II. Ease of Use
We understand the value of developing a technology that is easy to use. We know that if it’s not easy to use, then it won’t be used. Our technologies will always be thoughtfully constructed with application in mind.
Our desire is to improve the standard of care by producing safe and effective products. StimLabs will always aim to generate products that yield optimum results.
Utilizing these three concepts, we’ve set our sights on our main aspiration: improving patient outcomes. We look forward to serving the community and continuing the evolution of regenerative products.
MKTG 18-009 Rev 02